Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 22 | 2015 | 107 | 2.500 |
Why?
|
| Neurology | 6 | 2014 | 79 | 1.270 |
Why?
|
| Anticonvulsants | 14 | 2015 | 112 | 1.240 |
Why?
|
| International Classification of Diseases | 4 | 2015 | 23 | 1.150 |
Why?
|
| Nervous System Diseases | 6 | 2014 | 156 | 1.040 |
Why?
|
| Seizures | 5 | 2012 | 94 | 0.620 |
Why?
|
| International Agencies | 1 | 2015 | 5 | 0.500 |
Why?
|
| Hospitals, University | 1 | 2014 | 41 | 0.470 |
Why?
|
| Biomedical Research | 1 | 2014 | 80 | 0.440 |
Why?
|
| Global Health | 3 | 2002 | 58 | 0.440 |
Why?
|
| Education, Medical, Graduate | 2 | 2006 | 88 | 0.440 |
Why?
|
| Epilepsy, Temporal Lobe | 7 | 2016 | 50 | 0.410 |
Why?
|
| Carbamazepine | 6 | 2004 | 13 | 0.380 |
Why?
|
| Cyclohexanecarboxylic Acids | 5 | 2004 | 14 | 0.380 |
Why?
|
| Amines | 5 | 2004 | 15 | 0.380 |
Why?
|
| Humans | 56 | 2016 | 30997 | 0.370 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2004 | 48 | 0.370 |
Why?
|
| Epilepsies, Partial | 7 | 2010 | 24 | 0.360 |
Why?
|
| Poverty | 2 | 2008 | 97 | 0.330 |
Why?
|
| Cranial Irradiation | 1 | 2008 | 13 | 0.320 |
Why?
|
| Pharmacies | 1 | 2008 | 2 | 0.320 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 15 | 0.320 |
Why?
|
| Medication Errors | 1 | 2008 | 16 | 0.320 |
Why?
|
| Methotrexate | 1 | 2008 | 43 | 0.310 |
Why?
|
| Risk | 1 | 2008 | 221 | 0.300 |
Why?
|
| Intellectual Disability | 1 | 2008 | 48 | 0.300 |
Why?
|
| Antirheumatic Agents | 1 | 2008 | 93 | 0.300 |
Why?
|
| Status Epilepticus | 1 | 2008 | 51 | 0.290 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2008 | 105 | 0.280 |
Why?
|
| Child | 15 | 2016 | 1430 | 0.280 |
Why?
|
| World Health Organization | 4 | 2014 | 19 | 0.250 |
Why?
|
| Electroencephalography | 10 | 2011 | 136 | 0.250 |
Why?
|
| Adult | 31 | 2016 | 8931 | 0.240 |
Why?
|
| History, 21st Century | 2 | 2015 | 35 | 0.240 |
Why?
|
| History, 20th Century | 2 | 2015 | 70 | 0.240 |
Why?
|
| Fructose | 4 | 2004 | 12 | 0.230 |
Why?
|
| Adolescent | 20 | 2016 | 2401 | 0.220 |
Why?
|
| Female | 28 | 2016 | 16983 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2016 | 1311 | 0.210 |
Why?
|
| Acetates | 5 | 2004 | 19 | 0.200 |
Why?
|
| Epilepsy, Generalized | 4 | 2004 | 8 | 0.200 |
Why?
|
| Temporal Lobe | 4 | 1998 | 103 | 0.200 |
Why?
|
| Cognition | 1 | 2008 | 1427 | 0.170 |
Why?
|
| Male | 24 | 2016 | 16445 | 0.170 |
Why?
|
| Anterior Thalamic Nuclei | 2 | 2010 | 4 | 0.170 |
Why?
|
| Epilepsy, Complex Partial | 1 | 1998 | 7 | 0.150 |
Why?
|
| Somatoform Disorders | 1 | 1998 | 20 | 0.150 |
Why?
|
| Health Planning | 1 | 1998 | 5 | 0.150 |
Why?
|
| Preventive Medicine | 1 | 1998 | 12 | 0.150 |
Why?
|
| Mental Disorders | 3 | 2014 | 145 | 0.150 |
Why?
|
| Drug Industry | 1 | 1997 | 29 | 0.150 |
Why?
|
| Fecal Incontinence | 1 | 1997 | 3 | 0.150 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2016 | 81 | 0.140 |
Why?
|
| Public Health | 1 | 1998 | 68 | 0.140 |
Why?
|
| Urinary Incontinence | 1 | 1997 | 24 | 0.140 |
Why?
|
| Landau-Kleffner Syndrome | 1 | 1995 | 4 | 0.130 |
Why?
|
| Neurosurgical Procedures | 2 | 2016 | 162 | 0.130 |
Why?
|
| Cerebral Cortex | 2 | 2008 | 195 | 0.130 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2016 | 19 | 0.130 |
Why?
|
| Phenobarbital | 1 | 2015 | 5 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 62 | 0.130 |
Why?
|
| Drug and Narcotic Control | 1 | 2015 | 8 | 0.130 |
Why?
|
| Hemiplegia | 2 | 1992 | 9 | 0.120 |
Why?
|
| Propylene Glycols | 1 | 1995 | 4 | 0.120 |
Why?
|
| Body Weight | 1 | 1995 | 141 | 0.120 |
Why?
|
| Electric Stimulation Therapy | 2 | 2010 | 46 | 0.110 |
Why?
|
| Crying | 1 | 1993 | 1 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2015 | 191 | 0.110 |
Why?
|
| Monitoring, Physiologic | 2 | 2008 | 93 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 1998 | 991 | 0.110 |
Why?
|
| Forecasting | 1 | 2013 | 114 | 0.110 |
Why?
|
| Isoxazoles | 4 | 2004 | 17 | 0.100 |
Why?
|
| Child, Preschool | 6 | 2008 | 689 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2016 | 144 | 0.100 |
Why?
|
| Libido | 1 | 1992 | 7 | 0.100 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 1992 | 11 | 0.100 |
Why?
|
| Middle Aged | 18 | 2016 | 10195 | 0.100 |
Why?
|
| Headache | 2 | 2011 | 43 | 0.100 |
Why?
|
| Sexual Behavior | 1 | 1992 | 61 | 0.100 |
Why?
|
| Hippocampus | 3 | 2011 | 280 | 0.090 |
Why?
|
| Brain Neoplasms | 2 | 1989 | 133 | 0.090 |
Why?
|
| Deep Brain Stimulation | 2 | 2010 | 76 | 0.090 |
Why?
|
| Implantable Neurostimulators | 1 | 2010 | 15 | 0.090 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 40 | 0.090 |
Why?
|
| Diazepam | 2 | 2001 | 10 | 0.090 |
Why?
|
| Triazines | 5 | 2004 | 17 | 0.090 |
Why?
|
| Neuroblastoma | 1 | 1989 | 20 | 0.080 |
Why?
|
| Astrocytoma | 1 | 1989 | 25 | 0.080 |
Why?
|
| Patient Education as Topic | 2 | 2002 | 161 | 0.080 |
Why?
|
| Intelligence | 1 | 2008 | 26 | 0.080 |
Why?
|
| Disabled Persons | 2 | 2002 | 135 | 0.080 |
Why?
|
| Electrodiagnosis | 1 | 2008 | 4 | 0.080 |
Why?
|
| Epidural Space | 1 | 2008 | 26 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2008 | 93 | 0.080 |
Why?
|
| Vagus Nerve | 2 | 2000 | 16 | 0.070 |
Why?
|
| Drug Interactions | 3 | 2004 | 61 | 0.070 |
Why?
|
| Functional Laterality | 3 | 2011 | 88 | 0.070 |
Why?
|
| Training Support | 1 | 2006 | 7 | 0.070 |
Why?
|
| Societies, Scientific | 1 | 2006 | 12 | 0.070 |
Why?
|
| Treatment Outcome | 7 | 2015 | 3806 | 0.060 |
Why?
|
| Data Collection | 1 | 2006 | 109 | 0.060 |
Why?
|
| Levodopa | 2 | 1975 | 80 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2004 | 68 | 0.060 |
Why?
|
| Valproic Acid | 2 | 2011 | 30 | 0.050 |
Why?
|
| Specialty Boards | 1 | 2002 | 5 | 0.050 |
Why?
|
| Patient Advocacy | 1 | 2002 | 15 | 0.050 |
Why?
|
| International Cooperation | 1 | 2002 | 33 | 0.050 |
Why?
|
| Urban Health | 1 | 2002 | 24 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2006 | 227 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2002 | 56 | 0.050 |
Why?
|
| Tourette Syndrome | 1 | 1982 | 25 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 549 | 0.050 |
Why?
|
| Brain | 3 | 2008 | 1801 | 0.050 |
Why?
|
| United States | 3 | 2004 | 2375 | 0.050 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2000 | 1 | 0.040 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2000 | 4 | 0.040 |
Why?
|
| Nipecotic Acids | 3 | 2004 | 7 | 0.040 |
Why?
|
| Piracetam | 3 | 2004 | 15 | 0.040 |
Why?
|
| Folic Acid | 1 | 2000 | 16 | 0.040 |
Why?
|
| Managed Care Programs | 1 | 2000 | 12 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2000 | 83 | 0.040 |
Why?
|
| Amobarbital | 1 | 1999 | 3 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2010 | 499 | 0.040 |
Why?
|
| Movement Disorders | 3 | 1975 | 118 | 0.040 |
Why?
|
| Anesthetics, Intravenous | 1 | 1999 | 11 | 0.040 |
Why?
|
| Pregnancy | 1 | 2000 | 404 | 0.040 |
Why?
|
| Diet | 1 | 2000 | 194 | 0.040 |
Why?
|
| Videotape Recording | 1 | 1998 | 38 | 0.040 |
Why?
|
| Clinical Trials as Topic | 3 | 2004 | 330 | 0.040 |
Why?
|
| Social Conditions | 1 | 1998 | 1 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 5189 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2000 | 156 | 0.040 |
Why?
|
| Economics, Pharmaceutical | 1 | 1997 | 6 | 0.040 |
Why?
|
| National Health Programs | 1 | 1997 | 5 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 1998 | 46 | 0.040 |
Why?
|
| Drugs, Investigational | 1 | 1997 | 9 | 0.040 |
Why?
|
| Drug Costs | 1 | 1997 | 19 | 0.040 |
Why?
|
| Drug Utilization | 1 | 1997 | 30 | 0.040 |
Why?
|
| Health Care Reform | 1 | 1997 | 20 | 0.040 |
Why?
|
| Memory | 1 | 1999 | 328 | 0.040 |
Why?
|
| Young Adult | 2 | 2016 | 2063 | 0.040 |
Why?
|
| Health Policy | 1 | 1997 | 54 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 1998 | 109 | 0.030 |
Why?
|
| Methohexital | 1 | 1995 | 1 | 0.030 |
Why?
|
| Magnetoencephalography | 1 | 1995 | 4 | 0.030 |
Why?
|
| Pia Mater | 1 | 1995 | 6 | 0.030 |
Why?
|
| Morbidity | 1 | 1995 | 64 | 0.030 |
Why?
|
| Time Factors | 3 | 1999 | 1672 | 0.030 |
Why?
|
| Speech | 1 | 1995 | 28 | 0.030 |
Why?
|
| Deanol | 1 | 1975 | 1 | 0.030 |
Why?
|
| Myoclonus | 1 | 1975 | 24 | 0.030 |
Why?
|
| Ethanolamines | 1 | 1975 | 3 | 0.030 |
Why?
|
| Phenylcarbamates | 1 | 1995 | 3 | 0.030 |
Why?
|
| Treatment Failure | 1 | 1995 | 167 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 1999 | 1316 | 0.030 |
Why?
|
| Postoperative Period | 1 | 1995 | 302 | 0.030 |
Why?
|
| Drug Approval | 2 | 2004 | 31 | 0.030 |
Why?
|
| United States Food and Drug Administration | 2 | 2004 | 71 | 0.030 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1992 | 9 | 0.030 |
Why?
|
| Evidence-Based Medicine | 2 | 2004 | 216 | 0.030 |
Why?
|
| Risk Factors | 2 | 1998 | 2588 | 0.030 |
Why?
|
| Motor Cortex | 1 | 1992 | 17 | 0.030 |
Why?
|
| Age Factors | 3 | 2004 | 873 | 0.030 |
Why?
|
| Amphetamines | 1 | 1991 | 1 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1991 | 16 | 0.020 |
Why?
|
| Educational Status | 2 | 2011 | 312 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 71 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 111 | 0.020 |
Why?
|
| Acute Disease | 2 | 2004 | 231 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1992 | 429 | 0.020 |
Why?
|
| Administration, Rectal | 2 | 2001 | 8 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 335 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 85 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 243 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 1922 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2016 | 3658 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2010 | 177 | 0.020 |
Why?
|
| Electrodes | 1 | 2008 | 15 | 0.020 |
Why?
|
| Neurosurgery | 1 | 1988 | 49 | 0.020 |
Why?
|
| Microelectrodes | 1 | 2008 | 36 | 0.020 |
Why?
|
| Craniotomy | 1 | 2008 | 29 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1989 | 817 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 1009 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2008 | 75 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1989 | 583 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 430 | 0.020 |
Why?
|
| Autopsy | 1 | 2008 | 351 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 1992 | 1210 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 1987 | 164 | 0.020 |
Why?
|
| Depression | 1 | 2010 | 481 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1505 | 0.020 |
Why?
|
| Inflammation | 1 | 2008 | 362 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2004 | 2 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2004 | 2 | 0.020 |
Why?
|
| Biotransformation | 1 | 2004 | 8 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2004 | 9 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2004 | 40 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2004 | 52 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2004 | 70 | 0.010 |
Why?
|
| Epilepsy, Absence | 1 | 2004 | 2 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2004 | 5 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 215 | 0.010 |
Why?
|
| Evoked Potentials, Visual | 1 | 1984 | 4 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 226 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1984 | 11 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 144 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2004 | 60 | 0.010 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2004 | 135 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1982 | 50 | 0.010 |
Why?
|
| Reference Values | 1 | 1982 | 229 | 0.010 |
Why?
|
| Aged | 5 | 2001 | 10048 | 0.010 |
Why?
|
| Otitis Media | 1 | 2001 | 5 | 0.010 |
Why?
|
| Vomiting | 1 | 2001 | 18 | 0.010 |
Why?
|
| Drug Overdose | 1 | 2001 | 8 | 0.010 |
Why?
|
| Atrophy | 2 | 1998 | 100 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1998 | 208 | 0.010 |
Why?
|
| Self Care | 1 | 1998 | 91 | 0.010 |
Why?
|
| Recurrence | 1 | 1998 | 370 | 0.010 |
Why?
|
| Phosphenes | 1 | 1976 | 1 | 0.010 |
Why?
|
| Optic Neuritis | 1 | 1976 | 2 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1976 | 3 | 0.010 |
Why?
|
| Eye Movements | 1 | 1976 | 20 | 0.010 |
Why?
|
| Parkinson Disease | 2 | 1975 | 1069 | 0.010 |
Why?
|
| Trihexyphenidyl | 1 | 1975 | 2 | 0.010 |
Why?
|
| Methysergide | 1 | 1975 | 3 | 0.010 |
Why?
|
| Benztropine | 1 | 1975 | 3 | 0.010 |
Why?
|
| 5-Hydroxytryptophan | 1 | 1975 | 7 | 0.010 |
Why?
|
| Propranolol | 1 | 1975 | 10 | 0.010 |
Why?
|
| Amantadine | 1 | 1975 | 8 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1975 | 51 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 1975 | 14 | 0.010 |
Why?
|
| Dopamine Antagonists | 1 | 1975 | 12 | 0.010 |
Why?
|
| Amphetamine | 1 | 1975 | 10 | 0.010 |
Why?
|
| Serotonin | 1 | 1975 | 37 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1975 | 54 | 0.010 |
Why?
|
| Amygdala | 1 | 1995 | 50 | 0.010 |
Why?
|
| Hoarseness | 1 | 1994 | 2 | 0.010 |
Why?
|
| Paresthesia | 1 | 1994 | 6 | 0.010 |
Why?
|
| Tranquilizing Agents | 1 | 1974 | 1 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 1994 | 28 | 0.010 |
Why?
|
| Cough | 1 | 1994 | 12 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1975 | 442 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 1994 | 42 | 0.010 |
Why?
|
| Dementia | 1 | 1979 | 560 | 0.010 |
Why?
|
| Equipment Design | 1 | 1994 | 181 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 1994 | 167 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1979 | 1055 | 0.010 |
Why?
|
| Sleep | 1 | 1975 | 322 | 0.010 |
Why?
|
| Iofetamine | 1 | 1991 | 1 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1991 | 43 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1994 | 1133 | 0.010 |
Why?
|
| Glioma | 1 | 1988 | 54 | 0.000 |
Why?
|
| Animals | 1 | 1975 | 4723 | 0.000 |
Why?
|
| Dominance, Cerebral | 1 | 1984 | 20 | 0.000 |
Why?
|
| Photic Stimulation | 1 | 1984 | 44 | 0.000 |
Why?
|
| Pattern Recognition, Visual | 1 | 1984 | 31 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1984 | 190 | 0.000 |
Why?
|
| Multiple Sclerosis | 1 | 1976 | 84 | 0.000 |
Why?
|
| Thioridazine | 1 | 1974 | 6 | 0.000 |
Why?
|
| Chlorpromazine | 1 | 1974 | 8 | 0.000 |
Why?
|
| Gastritis | 1 | 1974 | 3 | 0.000 |
Why?
|
| Prochlorperazine | 1 | 1974 | 2 | 0.000 |
Why?
|
| Trifluoperazine | 1 | 1974 | 4 | 0.000 |
Why?
|
| Psychotic Disorders | 1 | 1974 | 47 | 0.000 |
Why?
|
| Anxiety Disorders | 1 | 1974 | 171 | 0.000 |
Why?
|